Following encouraging trial results, retatrutide, a new peptide therapy for treating type 2 metabolic disorder, has secured regulatory approval from Great Britain's Healthcare and Regulatory Agency ( https://shopretatrutidepeptide.com/category/retatrutide-peptide/